Increased atrial natriuretic peptide in an early stage of chronic glomerulonephritis

References

• Danielsen H, Pedersen EB. Renin-angiotensin-aldosterone system in exaggerated natriuresis of chronic glomerulonephritis. Scand J Clin Lab Invest 1984; 44: 693–702
   PubMed Web of Science ®Google Scholar
• Baldwin DS, Biggs AW, Goldring W, Hulet WH, Chasis H. Exaggerated natriuresis in essential hypertension. Am J Med 1958; 24: 893–902
   PubMed Web of Science ®Google Scholar
• Wiggins RC, Basar I, Slater JDH. Effect of arterial pressure and inheritance on the sodium excretory capacity of normal young men. Clin Sci 1978; 54: 639–47
   Web of Science ®Google Scholar
• Sørensen SS, Amdisen A, Pedersen EB. Abnormal proximal tubular sodium handling in nor-motensive patients with chronic glomerulonephritis and normal glomerular filtration rate. Scand J Clin Lab Invest 1987; 47: 785–91
   PubMed Web of Science ®Google Scholar
• Holstein-Rathlou N-H, Svendsen UG, Leyssac PP. Effects of acute volume loading on kidney function in patients with essential hypertension, as estimated by the lithium clearance method. J Hypertension 1985; 3: 511–6
   PubMed Web of Science ®Google Scholar
• Lang RE, Unger T, Ganten D. Atrial natriuretic peptide: A new factor in blood pressure control. J Hypertension 1987; 5: 255–71
   PubMed Web of Science ®Google Scholar
• Anderson JV, Raine AEG, Proudler A, Bloom SR. Effect of haemodialysis on plasma concentrations of atrialnatriuretic peptide in adult patients with chronic renal failure. J Endocrinol 1986; 110: 193–6
   PubMedGoogle Scholar
• Walker RG, Swainson CP, Yandle TG, Nichols MG, Espiner EA. Exaggerated responsiveness of immunoreactive atrial natriuretic peptide to saline infusion in chronic renal failure. Clin Sci 1987; 72: 19–24
   PubMed Web of Science ®Google Scholar
• Kappelgaard AM, Damkjaer Nielsen M, Giese J. Measurement of angiotensin II in human plasma: technical modification and practical experience. Clin Chim Acta 1976; 67: 299–306
   PubMed Web of Science ®Google Scholar
• Rask-Madsen J, Bruusgaard A, Munck O, Nielsen MD, Worming H. The significance of bile acids and aldosterone for the electrical hyperpo-larization of human rectum in obese patients treated with intestinal by-pass operation. Scand J Gastroenterol 1974; 9: 417–26
   PubMed Web of Science ®Google Scholar
• Pedersen EB, Danielsen H, Spencer ES. Effect of indapamide on renal plasma flow, glomerular filtration rate, and arginine-vasopressin in plasma in essential hypertension. Eur J Clin Pharmacol 1984; 26: 543–7
   PubMed Web of Science ®Google Scholar
• Robertson GL, Mahr EA, Athar S, Sinha T. Development and clinical application of a new method for the radioimmunoassay of arginine vasopressin in human plasma. J Clin Invest 1973; 52: 2340–53
   PubMed Web of Science ®Google Scholar
• Christensen P, Leyssac PP. A specific radioimmunoassay for PGE2 using an antibody with high specificity and a sephadex LH-20 microcolumn for separation of prostaglandins. Prostaglandins 1976; 11: 399–420
   PubMed Web of Science ®Google Scholar
• Powell WS. Rapid extraction of oxygenated metabolites of arachidonic acid from biological samples using octadecylsilyl silica. Prostaglandins 1980; 20: 947–57
   PubMed Web of Science ®Google Scholar
• Kimura T, Abe K, Ota K, Omata K, Shoji M, Kudo K, Matsui K, Inoue M, Yasujima M, Yoshinaga K. Effects of acute water load, hyper-tonic saline infusion, and furosemide administration on atrial natriuretic peptide and vasopressin release in humans. J Clin Endocrinol Metab 1986; 62: 1003–10
   PubMed Web of Science ®Google Scholar
• Sagnella GA, Markandu ND, Shore AC, Mac-Gregor GA. Changes in plasma immunoreactive atrial natriuretic peptide in response to saline infusion or to alterations in dietary sodium intake in normal subjects. J Hypertension 1986; 4(suppl. 2)S115–8
   Google Scholar
• Danielsen H, Pedersen EB, Christensen NJ. Relationship of angiotensin II. aldosterone, arginine vasopressin, adrenaline and noradrenaline in plasma, blood and extracellular volumes to blood pressure in chronic glomerulonephritis. Eur J Clin Invest 1986; 16: 85–90
   PubMed Web of Science ®Google Scholar
• Weidmann P, Hasler L, Gnädinger MP, Lang RE, Uehlinger DE, Shaw S, Rascher W, Reubi FC. Blood levels and renal effects of atrial natriuretic peptide in normal man. J Clin Invest 1986; 77: 734–42
   PubMed Web of Science ®Google Scholar
• Maack T, Marion DN, Camargo MJF, Kleinert HD, Laragh JH, Vaughan ED, Jr., Atlas SA. Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs. Am J Med 1984; 77: 1069–75
   PubMed Web of Science ®Google Scholar
• Burnett C, Jr., Granger JP, Opgenorth TJ. Effects of synthetic atrial natriuretic factor on renal function and renin release. Am J Physiol 1984; 247: F863–6
   PubMed Web of Science ®Google Scholar
• Cody RJ, Covit AB, Laragh JH, Atlas SA. Atrial natriuretic factors (ANF) in normal men: renal hemodynamic/hormonal responses. Hypertension 1985; 7: 845–52
   Web of Science ®Google Scholar
• Goodfriend TL, Elliott ME, Atlas SA. Actions of synthetic atrial natriuretic factor on bovine adrenal glomerulosa. Life Sci 1984; 35: 1675–82
   PubMed Web of Science ®Google Scholar
• Kudo T, Baird A. Inhibition of aldosterone production in the adrenal glomerulosa by atrial natriuretic factor. Nature 1984; 312: 756–7
   PubMed Web of Science ®Google Scholar
• Atarashi K, Muliow PJ, Franco-Saenz R. Effect of atrial peptides on aldosterone production. J Clin Invest 1985; 76: 1807–11
   PubMed Web of Science ®Google Scholar
• Kleinert HD, Maack T, Atlas SA, Januszewiez A, Sealey JE, Laragh JH. Atrial natriuretic factor inhibits angiotensin, norepinephrine-, and potassium-induced vascular contractility. Hypertension 1984; 6: 1143–7
   Web of Science ®Google Scholar
• Chartier L, Schiffrin E, Thibault G, Garcia R. Atrial natriuretic factor inhibits the stimulation of aldosterone secretion by angiotensin II. ACTH and potassium in vitro and angiotensin II-induced steroidogenesis in vivo. Endocrinology 1984; 115: 2026–8
   PubMed Web of Science ®Google Scholar
• Anderson JV, Struthers AB, Payne NN, Slater JDH, Bloom SR. Atrial natriuretic peptide inhibits the aldosterone response to angiotensin II in man. Clin Sci 1986; 70: 507–12
   PubMed Web of Science ®Google Scholar
• Laragh JH. Atrial natriuretic hormone, the renin-aldosterone axis and blood pressure-electrolyte homeostasis. N Engl J Med 1985; 313: 1330–40
   PubMed Web of Science ®Google Scholar
• Robertson GL. The reulation of vasopressin function in health and disease. Recent Prog Horm Res 1977; 33: 333–74
   Google Scholar
• Kirschenbaum MA, Serros ER. Are prostaglandins natriuretic?. Mineral Electrolyte Metab 1980; 3: 113–21
   Google Scholar
• Blum M, Bauminger S, Algueti A, Kisch E, Ayalon D, Aviram A. Urinary prostaglandin-E2 in chronic renal disease. Clin Nephrol 1981; 15: 87–9
   PubMed Web of Science ®Google Scholar
• Ciabattoni G, Cinotti GA, Pierucci A, Simonetti BM, Manzi M, Pugliese F, Barsotti P, Pecci G, Taggi F, Patrono C. Effects of sulindac and ibuprofen in patients with chronic glomerular disease. Evidence for the dependence of renal function on prostacyclin. N Engl J Med 1984; 310: 279–83
   PubMed Web of Science ®Google Scholar
• Kaojarern S, Chennavasin P, Burdette A, Campbell WB, Brater DC. Dependence of urinary prostaglandin E2 excretion on urinary volume rather than solute handling or segmental nephron function in man. Clin Sci 1984; 67: 413–20
   Web of Science ®Google Scholar